A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: A Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons

Clinical Infectious Diseases

Volumn 43, Issue 4, 2006, Pages 439-444

  Kawai, Naoki ^a,d   Ikematsu, Hideyuki ^a,b   Iwaki, Norio ^a   Maeda, Tetsunari ^a   Satoh, Ietaka ^a   Hirotsu, Nobuo ^a   Kashiwagi, Seizaburo ^c  

^a Japan Physician's Association   (Japan)

^b Haradoi Hospital   (Japan)

^c Japanese Red Cross Kyushu Block Blood Center   (Japan)

^d NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIGEN DETECTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FEVER; HUMAN; INFANT; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; PERSISTENT VIRUS INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME; VIRUS ISOLATION;

ACETAMIDES; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; JAPAN; MALE; MIDDLE AGED; OSELTAMIVIR; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33746634739     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/505868     Document Type: Article

References (23)

1. Kawai N, Ikematsu H, Iwaki N, et al. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season. Clin Infect Dis 2005; 40:1309-16.
2. Kawai N, Ikematsu H, Iwaki N, et al. The clinical outcomes of anti-influenza drug therapy: a Japanese multi-center study of the 2002/2003 influenza season. In: Kawaoka Y, ed. Options for control of influenza V. Amsterdam, The Netherlands: Elsevier Science Publishers, 2004:507-10.
3. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza. JAMA 2000; 283:1016-24.
4. Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet 2000; 355:827-35.
5. Nicholson KG, Aoki FY, Osterhaus ADME, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomized controlled trial. Lancet 2000; 355:1845-50.
6. McClellan K, Perry CM. Oseltamivir: a review of its use in influenza. Drugs 2001; 61:263-83.
7. Cooper NJ, Sutton AJ, Abrams KR, et al. Effectiveness of neuralminidase inhibitors in treatment and prevention of influenza A and B: systemic review and meta-analyses of randomized controlled trials. BMJ 2003; 326:1235-9.
8. Englund JA. Antiviral therapy of influenza. Semin Pediatr Infect Dis 2002; 13:120-8.
9. Aoki FY, Macleod MD, Paggiaro P, et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J. Antimicrob Chemother 2003; 51:123-9.
10. Gillissen A, Hoffken G. Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment. Med Microbiol Immunol 2002; 191:165-8.
11. Noyola DE, Demmler GJ. Effect of rapid diagnosis on management of influenza A infections. Pediatr Infect Dis J 2000; 19:303-7.
12. Uyeki TM. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J 2003; 22:164-77.
13. Ikematsu H, Yamaji K, Fukuda T, et al. Clinical evaluation of an immunochromatography test kit, Capilia FluA,B, for rapid diagnosis of influenza. In: Kawaoka Y, ed. Options for control of influenza V. Amsterdam, The Netherlands: Elsevier Science Publishers, 2004:372-5.
14. Hirotsu N, Ikematsu H, Iwaki N, et al. Effects of antiviral drugs on viral detection in influenza patients and on the sequential infection to their family members: serial examination by rapid diagnosis (Capilia) and virus culture. In: Kawaoka Y, ed. Options for control of influenza V. Amsterdam, The Netherlands: Elsevier Science Publishers, 2004:105-8.
15. Hara M, Takao S, Fukuda S, Shimazu Y, Miyazaki K. Comparison of three rapid diagnostic kits using immunochromatography for detection of influenza A viruses [in Japanese]. Kansenshogaku Zasshi 2004; 78:935-41.
16. Mitamura K, Yamazaki M, Ichikawa M, et al. Evaluation of an immunochromatography test using enzyme immunoassay for rapid detection of influenza A and B viruses [in Japanese]. Kansenshogaku Zasshi 2004; 78:597-603.
17. Kubo N, Ikematsu H, Nabeshima S, et al. Evaluation of an immunochromatography test kit for rapid diagnosis of influenza [in Japanese]. Kansenshogaku Zasshi 2003; 77:1007-14.
18. Hara M, Takao S, Fukuda S, et al. Comparison of four rapid diagnostic kits using immunochromatography to detect influenza B viruses [in Japanese]. Kansenshogaku Zasshi 2005; 79:803-11.
19. Yamazaki M, Mitamura K, Ichikawa M, et al. Evaluation of flow-through immunoassay for rapid detection of influenza A and B viruses [in Japanese]. Kansenshogaku Zasshi 2004; 78:865-71.
20. Kawai N, Ikematsu H, Iwaki N, et al. A prospective, internet based study of the effectiveness and safety of influenza vaccination in the 2001-2002 influenza season. Vaccine 2003; 21:4507-13.
21. Mendel DB, Tai CY, Escarpe PA, et al. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection. Antimicrob Agents Chemother 1998; 42:640-6.
22. Sidwell RW, Huffman JH, Barnard DL, et al. Inhibition of influenza virus infections in mice by G54104, an orally effective influenza virus neuraminidase inhibitor. Antiviral Res 1998; 37:107-20.
23. Boivin G, Goyette N. Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors. Antiviral Res 2002; 54:143-7.